These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9723312

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Conversion from tacrolimus to microemulsion formulation of cyclosporine in pediatric liver transplantation.
    Alberti D, Reding R, Otte JB, Falchetti D, Rigamonti W, Caccia G, Sokal E, de Ville de Goyet J.
    Transplant Proc; 1998 Aug; 30(5):1858-60. PubMed ID: 9723310
    [No Abstract] [Full Text] [Related]

  • 4. Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
    Reggiani P, Rossi G, Latham L, Caccamo L, Gatti S, Maggi U, Melada E, Paone G, Doglia M, Vannelli A, Fassati LR.
    Transplant Proc; 1998 Aug; 30(5):1855-6. PubMed ID: 9723308
    [No Abstract] [Full Text] [Related]

  • 5. Experience with neoral cyclosporine through the oral route in liver transplantation.
    Bilbao I, Lazaro JL, Pou L, Charco R, Hildalgo E, Murio E, Margarit C.
    Transplant Proc; 1998 Jun; 30(4):1432-4. PubMed ID: 9636580
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients.
    Van Buren D, Payne J, Geevarghese S, MacDonell R, Chapman W, Wright JK, Helderman JH, Richie R, Pinson CW.
    Transplant Proc; 1998 Aug; 30(5):1830-2. PubMed ID: 9723299
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral.
    Levy GA.
    Transplant Proc; 1996 Aug; 28(4):2252-3. PubMed ID: 8769216
    [No Abstract] [Full Text] [Related]

  • 18. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
    Bilbao I, Pou L, Allende E, Lázaro JL, Charco R, Hidalgo E, Margarit C.
    Transplant Proc; 2001 May; 33(3):2124-6. PubMed ID: 11377472
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Economic evaluation of Neoral versus Sandimmune maintenance therapy for de novo liver transplant patients: results from an International Randomized Controlled Trial. Milton Study Group.
    Peeters P, Kazek M, Abella I, Noble I.
    Transplant Proc; 1998 Aug; 30(5):1838-42. PubMed ID: 9723301
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.